NORATIS AG (NUVA.DE) Stock Fundamental Analysis

Europe - Frankfurt Stock Exchange - FRA:NUVA - DE000A2E4MK4 - Common Stock

0.328 EUR

+0.02 (+7.19%)

Last: 1/22/2026, 7:00:00 PM

Fundamental Rating

We assign a fundamental rating of 3 out of 10 to NUVA. NUVA was compared to 77 industry peers in the Real Estate Management & Development industry. NUVA has a bad profitability rating. Also its financial health evaluation is rather negative. NUVA has a decent growth rate and is not valued too expensively.

Quickly go to:

1. Profitability

1.1 Basic Checks

NUVA had negative earnings in the past year.
In the past year NUVA had a positive cash flow from operations.
In multiple years NUVA reported negative net income over the last 5 years.
In multiple years NUVA reported negative operating cash flow during the last 5 years.

1.2 Ratios

The Return On Assets of NUVA (-5.16%) is worse than 67.53% of its industry peers.
NUVA's Return On Equity of -38.04% is on the low side compared to the rest of the industry. NUVA is outperformed by 72.73% of its industry peers.
Looking at the Return On Invested Capital, with a value of 0.71%, NUVA is in line with its industry, outperforming 42.86% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for NUVA is below the industry average of 3.99%.

		Industry Rank	Sector Rank
ROA	-5.16%
ROE	-38.04%
ROIC	0.71%

ROA(3y)-2.47%

ROA(5y)-0.91%

ROE(3y)-16.73%

ROE(5y)-6.94%

ROIC(3y)1.9%

ROIC(5y)2.12%

1.3 Margins

The Operating Margin of NUVA (4.65%) is comparable to the rest of the industry.
NUVA's Operating Margin has declined in the last couple of years.
The Gross Margin of NUVA (17.76%) is comparable to the rest of the industry.
NUVA's Gross Margin has declined in the last couple of years.

		Industry Rank	Sector Rank
OM	4.65%
PM (TTM)	N/A
GM	17.76%

OM growth 3Y-20.54%

OM growth 5Y-12.31%

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-15.05%

GM growth 5Y-6.76%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), NUVA is destroying value.
NUVA has more shares outstanding than it did 1 year ago.
NUVA has more shares outstanding than it did 5 years ago.
NUVA has a worse debt/assets ratio than last year.

2.2 Solvency

NUVA has an Altman-Z score of 1.02. This is a bad value and indicates that NUVA is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 1.02, NUVA is in line with its industry, outperforming 58.44% of the companies in the same industry.
The Debt to FCF ratio of NUVA is 9.27, which is on the high side as it means it would take NUVA, 9.27 years of fcf income to pay off all of its debts.
NUVA has a better Debt to FCF ratio (9.27) than 76.62% of its industry peers.
A Debt/Equity ratio of 4.80 is on the high side and indicates that NUVA has dependencies on debt financing.
The Debt to Equity ratio of NUVA (4.80) is worse than 80.52% of its industry peers.

		Industry Rank	Sector Rank
Debt/Equity	4.8
Debt/FCF	9.27
Altman-Z	1.02

ROIC/WACC0.21

WACC3.42%

2.3 Liquidity

NUVA has a Current Ratio of 4.49. This indicates that NUVA is financially healthy and has no problem in meeting its short term obligations.
With an excellent Current ratio value of 4.49, NUVA belongs to the best of the industry, outperforming 87.01% of the companies in the same industry.
NUVA has a Quick Ratio of 4.49. This is a bad value and indicates that NUVA is not financially healthy enough and could expect problems in meeting its short term obligations.
NUVA has a Quick ratio of 0.19. This is in the lower half of the industry: NUVA underperforms 77.92% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	4.49
Quick Ratio	0.19

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 52.39% over the past year.
NUVA shows a strong growth in Revenue. In the last year, the Revenue has grown by 43.83%.
The Revenue has been decreasing by -2.61% on average over the past years.

EPS 1Y (TTM)52.39%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%64.45%

Revenue 1Y (TTM)43.83%

Revenue growth 3Y-3.3%

Revenue growth 5Y-2.61%

Sales Q2Q%8.18%

3.2 Future

The Earnings Per Share is expected to grow by 15.63% on average over the next years. This is quite good.
The Revenue is expected to grow by 9.40% on average over the next years. This is quite good.

EPS Next Y48.11%

EPS Next 2Y41.51%

EPS Next 3Y26.7%

EPS Next 5Y15.63%

Revenue Next Year-29.11%

Revenue Next 2Y8.43%

Revenue Next 3Y10.31%

Revenue Next 5Y9.4%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for NUVA. In the last year negative earnings were reported.
A Price/Forward Earnings ratio of 32.16 indicates a quite expensive valuation of NUVA.
NUVA's Price/Forward Earnings ratio is in line with the industry average.
When comparing the Price/Forward Earnings ratio of NUVA to the average of the S&P500 Index (24.32), we can say NUVA is valued slightly more expensively.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	32.16

4.2 Price Multiples

NUVA's Enterprise Value to EBITDA ratio is in line with the industry average.
Based on the Price/Free Cash Flow ratio, NUVA is valued cheaper than 98.70% of the companies in the same industry.

		Industry Rank	Sector Rank
P/FCF	0.12
EV/EBITDA	93.12

4.3 Compensation for Growth

NUVA's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
NUVA's earnings are expected to grow with 26.70% in the coming years. This may justify a more expensive valuation.